Partner Content Partner Content SMi’s Injectable Drug Delivery Releases an Exclusive Intervi... Injectable Drug Delivery 2018
Partner Content Partner Content SMi's Launch, Injectable Drug Delivery 2018 Hosts 2 Interact... Injectable Drug Delivery
Partner Content Partner Content Sanofi Joins the Speaker Line-up for SMi's Launch, Injectabl... Injectable Drug Delivery
Events Partner Content From the Pre-filled Syringes Portfolio, SMi Presents: Inject... Injectable Drug Delivery
Partner Content Partner Content Hear from MedImmune and Ipsen at SMi’s Injectable Drug Deliv... Launch of Injectable Drug Delivery
Partner Content Partner Content Discover Novel Based Vial Based Technology, Presented by Roc... Injectable Drug Delivery
News FDA clears Takeda, Protagonist's first-in-class PV drug Takeda and Protagonist's hepcidin mimetic rusfertide is the first hepcidin mimetic to be approved by the FDA for blood cancer polycythaemia vera.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
